# Methocarbamol in Ventral and Inguinal HR

> **NCT05388929** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Prisma Health-Upstate** · enrollment: 164 (actual)

## Conditions studied

- Ventral Hernia
- Inguinal Hernia

## Interventions

- **DRUG:** Methocarbamol
- **DRUG:** Standard Opioid
- **DRUG:** Standard opioid plus methocarbamol

## Key facts

- **NCT ID:** NCT05388929
- **Lead sponsor:** Prisma Health-Upstate
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-23
- **Primary completion:** 2026-06
- **Final completion:** 2026-12
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05388929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05388929, "Methocarbamol in Ventral and Inguinal HR". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05388929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*